Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease
Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson
Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson
View: Text | PDF
Research Article Inflammation Microbiology

Mucosal metabolites fuel the growth and virulence of E. coli linked to Crohn’s disease

  • Text
  • PDF
Abstract

Elucidating how resident enteric bacteria interact with their hosts to promote health or inflammation is of central importance to diarrheal and inflammatory bowel diseases across species. Here, we integrated the microbial and chemical microenvironment of a patient’s ileal mucosa with their clinical phenotype and genotype to identify factors favoring the growth and virulence of adherent and invasive E. coli (AIEC) linked to Crohn’s disease. We determined that the ileal niche of AIEC was characterized by inflammation, dysbiosis, coculture of Enterococcus, and oxidative stress. We discovered that mucosal metabolites supported general growth of ileal E. coli, with a selective effect of ethanolamine on AIEC that was augmented by cometabolism of ileitis-associated amino acids and glutathione and by symbiosis-associated fucose. This metabolic plasticity was facilitated by the eut and pdu microcompartments, amino acid metabolism, γ-glutamyl-cycle, and pleiotropic stress responses. We linked metabolism to virulence and found that ethanolamine and glutamine enhanced AIEC motility, infectivity, and proinflammatory responses in vitro. We connected use of ethanolamine to intestinal inflammation and L-fuculose phosphate aldolase (fucA) to symbiosis in AIEC monoassociated IL10–/– mice. Collectively, we established that AIEC were pathoadapted to utilize mucosal metabolites associated with health and inflammation for growth and virulence, enabling the transition from symbiont to pathogen in a susceptible host.

Authors

Shiying Zhang, Xochitl Morgan, Belgin Dogan, Francois-Pierre Martin, Suzy Strickler, Akihiko Oka, Jeremy Herzog, Bo Liu, Scot E. Dowd, Curtis Huttenhower, Matthieu Pichaud, Esra I. Dogan, Jack Satsangi, Randy Longman, Rhonda Yantiss, Lukas A. Mueller, Ellen J. Scherl, R. Balfour Sartor, Kenneth W. Simpson

×

Figure 1

The mucosal microbiome of AIEC shares the dysbiosis and culture of Enterococcus observed in a subset of patients with CD and UC.

Options: View larger image (or click on image) Download as PowerPoint
The mucosal microbiome of AIEC shares the dysbiosis and culture of Enter...
(A) Culture of ileal mucosa from patients with CD, UC, and NI. Fisher’s exact test (*P < 0.05, 2-tailed). (B) AIEC pathotype in cultured cells by strain and phylogroup (A, B1, B2, D, and nontypeable NT). Spearman correlation, phylogroup B1; P = 0.5935 and P < 0.05 (2-tailed). (C) Nonmetric multidimensional scaling (NMDS) ordination using Bray-Curtis distance. Stress = 0.16. Taxa with a significant fit to the ordination (P < 0.05, envfit) are shown. Line length corresponds to strength of association. The centroids of ileitis-positive samples (P < 0.001, R2 = 0.17, PERMANOVA) and AIEC-positive samples (P = 0.068, R2 = 0.05, PERMANOVA) are shown in red. (D) Taxa associated with disease phenotype, antibiotic use, and colonization by Enterococcus and AIEC. Kruskal-Wallis tests (Benjamini-Hochberg q < 0.25) were used to determine taxa with differential abundance between groups of interest. For all significant associations, effect size (η2) was calculated. Intensity of color corresponds to magnitude of effect, and color corresponds to direction of effect. Symbols indicate significance of association (**q < 0.01, *q < 0.05, +q < 0.1, ^q < 0.2). Color on y axis labels corresponds to phylum.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts